Sleep Therapy Devices
The U.S. sleep therapy device market is growing with rising sleep apnea prevalence, increasing diagnosis rates, and wider adoption of home-based and connected treatment technologies. Our research provides actionable insights into market size, technology adoption, competitive developments, and investment opportunities across CPAP systems, BiPAP devices, sleep monitors, masks, and diagnostic equipment.
The U.S. AI-enabled sleep therapy devices market is expanding rapidly, projected to grow from USD 6.78 billion in 2026 to USD 12.84 billion by 2032 at an 11.26% CAGR. Growth is propelled by escalating obstructive sleep apnea prevalence, CMS remote physiologic monitoring reimbursements, algorithm-driven auto-titrating CPAP platforms, and next-generation closed-loop hypoglossal nerve stimulation systems improving long-term clinical patient compliance.
Read Report Details
The U.S. digital sleep therapy devices market is expanding rapidly, driven by the escalating prevalence of sleep-disordered breathing and chronic insomnia. Valued at $6.16 billion in 2026, the sector is projected to reach $10.42 billion by 2032. Growth is fueled by cellular-connected positive airway pressure consoles, surgical neurostimulation systems, micro-sensor-enabled oral appliances, and cloud-integrated remote physiological patient monitoring platforms.
Read Report Details
The U.S. connected sleep therapy devices market is projected to expand from USD 3.93 billion in 2026 to USD 7.24 billion by 2032, advancing at a 10.72% CAGR. Growth is anchored by CMS ninety-day adherence mandates, decentralized home sleep apnea testing, embedded cellular IoT telemetry across APAP fleets, and cloud platforms automating durable medical equipment resupply workflows.
Read Report Details
The U.S. Portable Sleep Therapy Devices Market is rapidly expanding due to rising sleep apnea prevalence, out-of-pocket purchases by active travelers, and the miniaturization of positive airway pressure technology. Expected to reach $4.88 billion by 2032 at an 11.35% CAGR, the industry is transitioning from bulky bedside systems to pocket-sized micro-blowers, wearable positional bands, and 3D-printed oral appliances to ensure uncompromised mobility.
Read Report Details
The U.S. Home Sleep Therapy Devices Market is projected to grow from USD 4.25 billion in 2026 to USD 6.42 billion by 2032 at a 7.15% CAGR. Growth is driven by expanding home sleep apnea testing, high-adherence auto-CPAP adoption, cellular remote patient monitoring, and recurring mask resupply ecosystems serving over 30 million diagnosed sleep apnea patients nationwide.
Read Report Details
The U.S. Non-Invasive Sleep Therapy Devices Market is projected to expand from USD 6.48 billion in 2026 to USD 11.45 billion by 2032, advancing at a 9.95% CAGR. Expansion is driven by rising obstructive sleep apnea prevalence, decentralized home diagnostics, cloud telemetry compliance tracking, and recurring consumable demand across home healthcare and durable medical equipment distribution channels nationwide.
Read Report Details
The U.S. Positive Airway Pressure Devices Market is set to expand from USD 4.28 billion in 2026 to USD 6.48 billion by 2032, charting a 7.21% CAGR. Market momentum is driven by high obstructive sleep apnea prevalence, the rapid shift to home sleep testing, auto-titrating device dominance, and payor adherence mandates powered by integrated cellular cloud telemetry.
Read Report Details
The U.S. central sleep apnea devices market is positioned for robust growth, expanding from USD 1.54 billion in 2026 to USD 2.92 billion by 2032 at an 11.25% CAGR. Expansion is driven by escalating cardiovascular comorbidities, clinical adoption of transvenous phrenic nerve stimulation, advanced adaptive servo-ventilation workstations, and streamlined outpatient Medicare reimbursement across hospital and home healthcare channels.
Read Report Details
The U.S. Obstructive Sleep Apnea Devices Market is projected to grow from USD 6.48 billion in 2026 to USD 11.24 billion by 2032, advancing at a 9.61% CAGR. Growth is driven by expanding home sleep testing, rising cardiovascular comorbidity screening, cloud-connected positive airway pressure systems, and rapid clinical adoption of implantable neurostimulation and custom dental oral appliances across care settings.
Read Report Details
The U.S. Sleep Apnea Therapy Devices Market is projected to grow from USD 7.68 billion in 2026 to USD 13.85 billion by 2032, exhibiting a 10.33% CAGR. Growth is fueled by high diagnostic rates, cellular remote monitoring, and automated consumable resupply, alongside expanding clinical adoption of hypoglossal nerve stimulation and custom oral appliances across diverse home and ambulatory surgical settings.
Read Report Details